MEDEPOCH

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke MEDEPOCH wurde als Wortmarke am 08.06.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 24. Februar 2023

Markenform Wortmarke
Aktenzeichen 1558883
Länder Australien Kanada China Europäische Gemeinschaft Großbritannien Indien Japan Nordkorea Neuseeland Singapur
Basismarke US Nr. 88773853, 27. Januar 2020
Anmeldedatum 08. Juni 2020
Ablaufdatum 09. August 2021

Markeninhaber

17301 W. Colfax Avenue,
Suite 152
US

Markenvertreter

3000 K Street, N.W., Sixth Floor Washington DC 20007 US

Waren und Dienstleistungen

09 Software in the fields of healthcare, medicine and wellness for use in patient communication, patient care, dynamic collection of patient related health and wellness data, care coordination and care management, chronic disease management, remote patient monitoring and engagement between health care providers and patients; downloadable electronic reports featuring health information, health data analysis and clinical insights; downloadable application programming interface (API) software; providing an interactive web-based and mobile application featuring technology that enables care providers and users to enter, access, track, monitor and generate health and medical information and reports (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations)
10 Wearable medical device for monitoring vital signs, heart rate, respiratory rate, body position, activity level, gait, temperature, quality of sleep, motion and symptomatic events in the nature of coughing, sneezing, vomiting, and fall detection; providing medical device hardware and software, sold as a unit, for recording, transmitting, analyzing and reporting patient health data and clinical insights to care providers (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations)
42 Data-as-a-service (DaaS) services featuring software for collection, verification, aggregation, storage, management, distribution, transmission and visualization of health-related data; software as a service (SaaS) services featuring software for integrating and analyzing patient health data for predictive analysis of health risks and health events; providing an interactive web platform featuring technology that enables care providers and users to enter, access, track, monitor and generate health and medical information and reports (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); providing a (computer software) cloud-based analytics platform for recording, transmitting, analyzing and reporting patient health data and clinical insights to care providers (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); platform as a service (PaaS) featuring a computer software platform in the fields of healthcare, medicine and wellness for patient communication, patient care, dynamic collection of patient related health and wellness data, care coordination and care management, chronic disease management, remote patient monitoring and engagement between health care providers and patients; software as a service (SaaS) featuring software in the fields of healthcare, medicine and wellness for the purpose of providing an integrated health management system using machine learning and artificial intelligence, namely, software for providing patients and health care providers access to patient information and data, for dynamic collection of patient related health and wellness data and for providing patients access to personalized information relevant to patient health and wellbeing; providing electronic reports in the field of early identification, detection and screening of adverse health events, health trends and complex health conditions via online non-downloadable software; providing temporary use of on-line non-downloadable Software as a Medical Device (SaMD) used as a diagnostic tool for early identification, detection and screening of adverse health events, health trends and complex health conditions; providing temporary use of on-line algorithmic non-downloadable software that analyzes, tracks and reports health data to allow medical professionals to determine courses of treatment and initiate proactive interventions and providing electronic reports associated therewith
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
30. August 2022 2022/40 Gaz NZ RAW: Rule 18ter(2)(ii) GP following a provisional refusal
08. April 2022 2022/26 Gaz US RAW: Total Ceasing Effect
18. Februar 2022 2022/9 Gaz CA Ablehnung
01. Januar 2022 2022/2 Gaz SG Ablehnung
07. Oktober 2021 2021/40 Gaz JP Ablehnung
25. Mai 2021 2021/23 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
15. Mai 2021 2021/20 Gaz GB RAW: Rule 18ter(2)(ii) GP following a provisional refusal
03. Mai 2021 2021/18 Gaz IN Ablehnung
04. März 2021 2021/10 Gaz CN Ablehnung
04. März 2021 2021/10 Gaz NZ Ablehnung
13. Januar 2021 2021/3 Gaz SG Ablehnung
18. Dezember 2020 2020/52 Gaz GB Ablehnung
02. Dezember 2020 2020/50 Gaz AU Ablehnung
24. November 2020 2020/49 Gaz EM Ablehnung
08. Juni 2020 2020/43 Gaz US Eintragung

ID: 141558883